Novel Phosphorous Triamides
3
3
3Ј), 25.7 (d, JC,P = 5 Hz, C-2), 27.3 (d, JC,P = 5 Hz, C-2Ј), 32.4 as for L3, but diisopropylamine was used for the synthesis instead
2
2
(C-3), 46.3 (d, JC,P = 16 Hz, C-1Ј), 50.4 (d, JC,P = 40 Hz, C-1),
of piperidine. Quantities: diisopropylamine: 0.47 mL, 0.336 g,
2
2
54.3 (d, JC,P = 7 Hz, C-5), 62.7 (d, JC,P = 8 Hz, C-4), 115.6 (d, 3.32 mmol; 7: 0.400 g, 1.66 mmol. Product: colourless solid
3JC,P = 12 Hz, C-6), 118.2 (C-8), 129.2 (C-7), 147.4 (d, JC,P
=
(0.441 g, 87% yield).
2
14 Hz, Cq) ppm. 31P{1H} NMR (C6D6): δ = 114.7 and 95.7 ppm;
ratio 45:1. HRMS: calculated: 289.1708; found: 289.1670.
(3aS)-2-Phenyl-1-(pyrrolidin-1-yl)-hexahydro-1H-pyrrolo[1,2-c]-
[1,3,2]diazaphosphole (L4): The same procedure was applied as for
L3, but pyrrolidine was used for the synthesis instead of piperidine.
Quantities: pyrrolidine: 0.42 mL, 0.356 g, 5.0 mmol; 7: 0.600 g,
2.5 mmol. Product: colourless solid (0.406 g, 59% yield).
3
1H NMR (C6D6): δ = 1.13 (d, JH,H = 7.1 Hz, 6 H, 1Ј-H, 2Ј-H),
3
1.14–1.19 (m, 1 H, 3-H), 1.25 (d, JH,H = 7.1 Hz, 6 H, 4Ј-H, 5Ј-H),
1.36–1.43 (m, 2 H, 2-H), 1.54–1.60 (m, 1 H, 3-H), 2.73–2.77 (m, 1
H, 5-H), 2.94–3.10 (m, 1 H, 1-H), 3.30–3.36 (m, 2 H, 3Ј-H, 6Ј-H),
3.36–3.42 (m, 1 H, 1-H), 3.52–3.55 (m, 1 H, 5-H), 3.69–3.75 (m, 1
3
3
H, 4-H), 6.83 (t, JH8,H7 = 7.3 Hz, 1 H, 8-H), 7.16 (d, JH6,H7
=
3
3
8.3 Hz, 2 H, 6-H), 7.27 (dd, JH7,H6 = 8.3, JH7,H8 = 7.3 Hz, 2 H,
7-H) ppm. 13C NMR (C6D6): δ = 23.7 (d, JC,P = 6 Hz, C-1Ј, C-
3
1H NMR (C6D6): δ = 1.17–1.23 (m, 1 H, 3-H), 1.37–1.47 (m, 5 H,
2Ј-H, 3Ј-H, 2-H), 1.55–1.62 (m, 1 H, 3-H), 2.76–2.80 (m, 1 H, 5-
H), 2.96–3.01 (m, 2 H, 1Ј-H, 4-HЈ), 3.03–3.09 (m, 1 H, 1-H), 3.14–
3.19 (m, 2 H, 1Ј-H, 4Ј-H), 3.39–3.47 (m, 2 H, 5-H, 1-H), 3.78–3.83
(m, 1 H, 4-H), 6.84 (t, 3JH8,H7 = 7.4 Hz, 1 H, 8-H), 7.06 (d, 3JH6,H7
= 8.9 Hz, 2 H, 6-H), 7.27 (dd, JH7,H6 = 8.9, JH7,H8 = 7.4 Hz, 2 H,
2Ј), 24.8 (d, 3JC,P = 10 Hz, C-4Ј, C-5Ј), 25.7 (d, 3JC,P = 5 Hz, C-2),
2
2
32.6 (C-3), 45.3 (d, JC,P = 10 Hz, C-3Ј, C-6Ј), 49.5 (d, JC,P
=
2
2
42 Hz, C-1), 54.7 (d, JC,P = 6 Hz, C-5), 61.8 (d, JC,P = 7 Hz, C-
4), 116.0 (d, 3JC,P = 11 Hz, C-6), 118.1 (C-8), 129.0 (C-7), 147.2 (d,
2JC,P = 14 Hz, Cq) ppm. 31P{1H} NMR (C6D6): δ = 107.0 ppm.
HRMS: calculated: 305.2021; found: 305.2020.
3
7-H) ppm. 13C NMR (C6D6): δ = 25.8 (d, JC,P = 3 Hz, C-2Ј, C-
3
2
3Ј), 26.5 (d, JC,P = 4 Hz, C-2), 32.4 (C-3), 46.6 (d, JC,P = 14 Hz,
(3aS)-N,N-Dibutyl-2-phenyl-hexahydro-1H-pyrrolo[1,2-c][1,3,2]di-
azaphosphol-1-amine (L7): The same procedure was applied as for
L3, but dibutylamine was used for the synthesis instead of piperi-
dine. Quantities: dibutylamine: 0.28 mL, 0.214 g, 1.66 mmol; 1:
0.200 g, 0.83 mmol. Product: colourless oil (0.255 g, 92% yield).
2
2
C-1Ј, C-4Ј), 50.8 (d, JC,P = 40 Hz, C-1), 54.7 (d, JC,P = 5 Hz, C-
2
3
5), 63.1 (d, JC,P = 8 Hz, C-4), 115.2 (d, JC,P = 13 Hz, C-6), 118.0
(C-8), 129.3 (C-7), 147.4 (d, JC,P = 14 Hz, Cq) ppm. 31P{1H}
2
NMR (C6D6): δ = 107.3 and 91.7 ppm; ratio 80:1. HRMS: calcu-
lated: 275.1551; found: 275.1542.
4-[(3aS)-2-Phenyl-hexahydro-1H-pyrrolo[1,2-c][1,3,2]diazaphosphol-
1-yl]morpholine (L5): The same procedure was applied as for L3,
but morpholine was used for the synthesis instead of piperidine.
Quantities: morpholine: 0.150 mL, 0.143 g, 1.66 mmol; 7: 0.200 g,
0.83 mmol. Product: colourless solid (0.148 g, 61% yield).
3
1H NMR (C6D6): δ = 0.84 (t, JH,H = 7.3 Hz, 6 H, 4Ј-H), 1.10–
1.30 (m, 5 H, 3Ј-H, 3-H), 1.31–1.46 (m, 6 H, 2Ј-H, 2-H), 1.53–1.64
(m, 1 H, 3-H), 2.81–2.86 (m, 1 H, 5-H), 2.88–2.95 (m, 2 H, 1Ј-H),
2.98–3.04 (m, 1 H, 1-H), 3.10 (m, 2 H, 5Ј-H), 3.44–3.50 (m, 1 H,
1-H), 3.52–3.56 (m, 1 H, 5-H), 3.78–3.83 (m, 1 H, 4-H), 6.82 (t,
3
3JH8,H7 = 7.3 Hz, 1 H, 8-H), 7.05 (d, JH6,H7 = 8.2 Hz, 2 H, 6-H),
1H NMR (C6D6): δ = 1.10–1.17 (m, 1 H, 3-H), 1.30–1.37 (m, 2 H, 7.26 (dd, 3JH7,H6 = 8.2, 3JH7,H8 = 7.3 Hz, 2 H, 7-H) ppm. 13C NMR
3
2-H), 1.48–1.56 (m, 1 H, 3-H), 2.48 (m, 2 H, 2Ј-H), 2.70–2.74 (m,
1 H, 5-H), 2.82–2.99 (m, 3 H, 3Ј-H, 1-H), 3.31–3.44 (m, 4 H, 1-H,
(C6D6): δ = 14.1 (C-4Ј), 20.6 (C-3Ј), 25.9 (d, JC,P = 4 Hz, C-2),
2
31.4 (C-2Ј), 32.7 (C-3), 46.0 (d, JC,P = 18 Hz, C-1Ј, C-5Ј), 50.1 (d,
5-H, 4Ј-H), 3.45–3.47 (m, 2 H, 1Ј-H), 3.57–3.64 (m, 1 H, 4-H), 6.86 2JC,P = 43 Hz, C-1), 54.4 (d, JC,P = 7 Hz, C-5), 62.5 (d, JC,P
=
2
2
3
3
3
(t, JH8,H7 = 7.3 Hz, 1 H, 8-H), 7.06 (d, JH6,H7 = 7.8 Hz, 2 H, 6-
8 Hz, C-4), 115.6 (d, JC,P = 12 Hz, C-6), 118.1 (C-8), 129.1 (C-7),
H), 7.26 (dd, JH7,H6 = 7.8, JH7,H8 = 7.3 Hz, 2 H, 7-H) ppm. 13C
147.3 (d, 2JC,P = 14 Hz, Cq) ppm. 31P{1H} NMR (C6D6): δ = 118.2
3
3
3
NMR (C6D6): δ = 25.7 (d, JC,P = 4 Hz, C-2), 32.3 (C-3), 45.6 (d, and 97.6 (47:1) ppm. HRMS: calculated: 333.2334; found:
3JC,P = 12 Hz, C-3Ј), 46.4 (C-2Ј), 50.3 (d, 2JC,P = 38 Hz, C-1), 54.4
333.2331.
2
2
2
(d, JC,P = 6 Hz, C-5), 62.8 (d, JC,P = 7 Hz, C-4), 67.7 (d, JC,P
=
(3aS)-N-Methyl-2-phenyl-N-[(R)-1-phenylethyl]-hexahydro-1H-pyr-
rolo[1,2-c][1,3,2]diazaphosphol-1-amine (L8): DMAP (0.406 g,
3.32 mmol) was added to a stirred solution of 1 (0.800 g,
3.32 mmol) in toluene (5 mL), and the mixture was stirred for
10 min. (R)-N-Methyl-1-phenylethylamine (0.48 mL, 0.449 g,
3.32 mmol) was added neat by syringe, and the mixture was stirred
overnight at room temperature. The formed colourless precipitate
2
3
18 Hz, C-4Ј), 67.8 (d, JC,P = 6 Hz, C-1Ј), 115.6 (d, JC,P = 11 Hz,
2
C-6), 118.5 (C-8), 129.2 (C-7), 147.0 (d, JC,P = 14 Hz, Cq) ppm.
31P{1H} NMR (C6D6): δ = 114.5 and 95.0 ppm; ratio 90:1. HRMS:
calculated: 291.1501; found: 291.1493.
(3aS)-N,N-Diisopropyl-2-phenyl-hexahydro-1H-pyrrolo[1,2-c]-
[1,3,2]diazaphosphol-1-amine (L6): The same procedure was applied
Eur. J. Org. Chem. 2009, 4102–4116
© 2009 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
4113